Brain Control Articles & Analysis
20 news found
” About Amyotrophic Lateral Sclerosis (ALS) ALS, also known as Lou Gehrig’s Disease, is a rare, progressive, debilitating, and universally fatal neurodegenerative disease affecting the motor neurons connecting the brain and spinal cord. Degeneration of these neurons leads to paralysis as the brain loses its ability to control muscle ...
Synchron, an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States. ...
The Relivion DP is the first non-invasive, multi-channel brain neuromodulation system for at home treatment of neurological and neuropsychiatric disorders. ...
This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is designed to be used at home, and to share treatment data with each patient’s physician, in addition to uploading the data to the cloud database through a dedicated app. ...
It is designed to concurrently neuromodulate major neural pathways in the head, and thereby affect brain regions that are involved in control and modulation of mood and pain. ...
Kurve Therapeutics has succeeded in bypassing the blood-brain barrier with their patented Controlled Particle Dispersion® (CPD) technology, creating new hope in the treatment of central nervous system disorders. ...
It is designed to concurrently neuromodulate major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of mood and pain. ...
“Our research is exciting because while other devices require surgery that involves opening the skull, this brain-computer interface device is much less invasive. It receives electrical signals from the brain, allowing people to control a computer by ...
The CoBot then intends to automatically align the pedicle targeting instruments on the chosen trajectory, leaving the surgeon in control of the workflow in the sterile zone. The robotic arm is currently not available for sale, CE marking is in progress. ...
The product, Modius, claims to stimulate the part of the brain that controls fat storage and metabolism. The company, Modius Health, was set up by neuroscientist Dr Jason McKeown from Portglenone, County Antrim in 2013. ...
Outcomes will include the use of the brain data to control digital devices and achieve improvements in functional independence. ...
And he found them in a surprising place: the side of the brain that had not been injured by the stroke. Usually, the brain and body follow what's known as a contralateral model, where the right side of the brain controls the left side of the body. But Leuthardt's team had discovered that control signals were ...
This allows for the release of neurotransmitters in the brainstem and modulation of brain networks associated with control of pain. The FDA marketing clearance is based on the results of a multi-center, prospective, randomized, double-blind, placebo-controlled clinical study. ...
This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is designed to allow patients to use Relivion® at home, and share treatment data with their physician, in addition to uploading the data to the cloud database through a dedicated app. ...
“This may explain why it is the only neuromodulation technology that was able to demonstrate statistically significant results for complete freedom of migraine symptoms, in a placebo-controlled clinical trial,” added Dr. Tepper. The Relivion® enables neuromodulation of brain networks associated with control of pain and other ...
Neurolief, a medical neurotechnology innovator, today announces that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Relivion®DP system, the first non-invasive multi-channel brain neuromodulation technology, for the treatment of major depression. ...
By relocating to the Newark-based university, the company has been able to tap into the institution’s human and financial resources, allowing it to keep costs at a minimum as it develops its product: a spray gel used to control bleeding during brain ...
NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with Parkinson’s disease. ...
Regular exercise could help prevent brain damage associated with neurodegenerative diseases like Alzheimer’s, according to research published this month in Elsevier’s journal Brain, Behavior, and Immunity. ...
Regular exercise could help prevent brain damage associated with neurodegenerative diseases like Alzheimer’s, according to research published this month in Elsevier’s journal Brain, Behavior, and Immunity. ...